Univest
Univest
  • Markets

Piramal Pharma Share Price Rising Today: Up 3.05% to Rs 182.51

  • July 23, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Piramal Pharma Share Price Rising Today:

Piramal Pharma CMP Rs 182.51, +5.41 (3.05%) as of 23 Jul 2026. Volume 62,81,009 shares.

Piramal Pharma share price is rose 3.05% to trade at Rs 182.51 in today’s session on 23 July 2026, moving Rs 5.41 from the previous close on trading volume of 62,81,009 shares.

The move places Piramal Pharma among the top gainers on the exchanges in today’s session, drawing attention from traders tracking momentum stocks.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Piramal Pharma Share Price Snapshot Today
  • Why Piramal Pharma Is Rising Today
  • Broader Market Context
  • What Investors Should Watch Next
  • Conclusion
  • FAQs on Piramal Pharma Share Price Today
    • Why is Piramal Pharma share price rise today?
    • What is Piramal Pharma’s share price today?
    • What is the trading volume in Piramal Pharma today?
    • Is there any news driving Piramal Pharma share price today?
    • Should I buy Piramal Pharma after today’s price move?
    • What are the key levels to watch for this stock?
    • Where can I track live price and updates?

Piramal Pharma Share Price Snapshot Today

Metric Value
Company Piramal Pharma
CMP (23 Jul 2026) Rs 182.51
Change +5.41 (3.05%)
Volume 62,81,009 shares

Learn More About Univest, a SEBI Registered Investment Advisor

Why Piramal Pharma Is Rising Today

Today’s move appears driven by a mix of stock specific positioning and broader sector momentum rather than a single confirmed news trigger. Volume of 62,81,009 shares in the counter today is a useful gauge of how much conviction is behind the move compared to the stock’s typical trading activity.

Investors watching Piramal Pharma share price should track whether the move sustains into the closing session or fades, since intraday swings can reverse sharply, particularly in stocks with lower average trading volumes.

Broader Market Context

Today’s session has seen a mix of stock specific movers alongside broader index direction, with global cues including crude oil price swings on US-Iran tensions and a busy Q1 FY27 earnings calendar shaping sentiment across sectors. Piramal Pharma share price action should be read alongside this wider market backdrop rather than in isolation.

Sector peers have also seen a range of reactions today, underlining that stock specific factors are driving individual outcomes as much as broad market direction.

Download the Univest iOS App or Univest Android App to track Piramal Pharma live price and get daily stock recommendations.

What Investors Should Watch Next

Investors tracking Piramal Pharma should watch trading volumes, any fresh corporate announcements, and how the stock behaves relative to its recent support and resistance levels in the sessions ahead.

Use the Univest Screener to compare Piramal Pharma against sector peers on valuation and momentum before making any investment decision. Short term price swings should be weighed against the company’s longer term fundamentals.

Conclusion

Piramal Pharma rose 3.05% in today’s session to trade at Rs 182.51. Investors should track further price action and volumes in the coming sessions, and consult a SEBI-registered advisor before making any investment decision.

Piramal Pharma share price remains a key data point for traders this week.

Tracking Piramal Pharma share price closely can help investors time entries around today’s volatility.

The Piramal Pharma share price move today adds to a busy session of stock specific reactions across the market.

Piramal Pharma share price trends will be watched alongside sector peers moving today.

Traders watching Piramal Pharma share price today are also weighing broader index direction.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Piramal Pharma Share Price Today

Why is Piramal Pharma share price rise today?

Ans. Piramal Pharma share price rose 3.05% to Rs 182.51 in today’s session on 23 July 2026. Today’s move appears driven by a mix of stock specific positioning and broader sector momentum rather than a single confirmed news trigger.

What is Piramal Pharma’s share price today?

Ans. Piramal Pharma share price is at Rs 182.51 as of 23 July 2026, up 3.05% for the session.

What is the trading volume in Piramal Pharma today?

Ans. Piramal Pharma has recorded a trading volume of 62,81,009 shares in today’s session as of the time of writing.

Is there any news driving Piramal Pharma share price today?

Ans. No single confirmed news trigger was tied to today’s move; it appears to reflect a mix of stock specific positioning and sector momentum.

Should I buy Piramal Pharma after today’s price move?

Ans. This article is for informational purposes only and is not investment advice. Investors should evaluate the stock in the context of their own portfolio and consult a SEBI-registered investment advisor before making any investment decision.

What are the key levels to watch for this stock?

Ans. Investors should track Piramal Pharma share price against its recent support and resistance levels, along with volume trends, to gauge whether today’s move can sustain.

Where can I track live price and updates?

Ans. Investors can track Piramal Pharma’s live share price, volumes and news on the Univest platform.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply